West Pharmaceutical Services Inc (WST)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 574,500 575,800 591,800 643,500 676,000 613,700 575,500 621,400 655,800 741,200 783,500 766,400 752,300 684,400 602,200 494,500 406,900 368,900 337,000 313,900
Revenue (ttm) US$ in thousands 2,893,100 2,876,300 2,876,800 2,928,600 2,949,800 2,926,500 2,866,000 2,883,500 2,886,900 2,909,000 2,928,600 2,880,900 2,831,600 2,681,000 2,522,500 2,326,100 2,146,900 2,037,300 1,945,400 1,887,900
Operating profit margin 19.86% 20.02% 20.57% 21.97% 22.92% 20.97% 20.08% 21.55% 22.72% 25.48% 26.75% 26.60% 26.57% 25.53% 23.87% 21.26% 18.95% 18.11% 17.32% 16.63%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $574,500K ÷ $2,893,100K
= 19.86%

The operating profit margin of West Pharmaceutical Services Inc has shown a generally increasing trend from March 2020 to June 2022, reaching a peak of 26.75% in June 2022. This indicates that the company was effectively managing its operating expenses in relation to its revenue during this period.

However, from September 2022 onwards, the operating profit margin started to decline gradually, dropping to 19.86% by December 2024. This decrease suggests that the company may have faced challenges in controlling its operating costs or experienced a decrease in revenue relative to its expenses during this period.

Overall, the operating profit margin data reveals both strengths and potential areas of concern in West Pharmaceutical Services Inc's ability to generate profits from its core operations over the analyzed period.


Peer comparison

Dec 31, 2024

Company name
Symbol
Operating profit margin
West Pharmaceutical Services Inc
WST
19.86%
Carlisle Companies Incorporated
CSL
22.67%